Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe completed ganaxolone study record is displayed, with details about its design, participant criteria, study locations, and seizure-related outcomes. The page also includes the study protocol and statistical analysis plan.SummaryDifference48%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide notice appears announcing updates and FAQs about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, signaling an access restriction rather than an update to the study details.SummaryDifference17%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.